Predicting survival of cancer patients by chromosomal copy number heterogeneity.

Van Den Bosch, Tom; van Dijk, Erik; Vermeulen, Louis; Miedema, Daniël M

Van Den Bosch, Tom; van Dijk, Erik; Vermeulen, Louis; Miedema, Daniël M.

Afiliação

Van Den Bosch T; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Dijk E; Oncode Institute, Amsterdam, The Netherlands.
Vermeulen L; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Mol Cell Oncol ; 8(4): 1949956, 2021.

Article em En | MEDLINE | ID: mdl-34616875

Palavras-chave

Biomarker; chromosomal instability; intra-tumor heterogeneity; pan-cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Cell Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google